Evidence map›Paper›PMID 26961734›Full record

ArticleNature communications2016

Correspondence: SEMA4A variation and risk of colorectal cancer.

Ben Kinnersley, Daniel Chubb, Sara E Dobbins, Matthew Frampton, Stephan Buch, Maria N Timofeeva, Sergi Castellví-Bel, Susan M Farrington, Asta Forsti, Jochen Hampe and 14 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Ben KinnersleyDivision of Genetics and Epidemiology, The Institute of Cancer Research, Surrey, Sutton SM2 5NG, UK.
Daniel ChubbDivision of Genetics and Epidemiology, The Institute of Cancer Research, Surrey, Sutton SM2 5NG, UK.
Sara E DobbinsDivision of Genetics and Epidemiology, The Institute of Cancer Research, Surrey, Sutton SM2 5NG, UK.
Matthew FramptonDivision of Genetics and Epidemiology, The Institute of Cancer Research, Surrey, Sutton SM2 5NG, UK.
Stephan BuchDepartment of Medicine I, University Hospital Dresden, Dresden 23538, Germany.
Maria N TimofeevaColon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh EH4 2XU, UK.
Sergi Castellví-BelDepartment of Gastroenterology, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Institut d'Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona, Catalonia, Barcelona 8036, Spain.
Susan M FarringtonColon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh EH4 2XU, UK.
Asta ForstiGerman Cancer Research Center, Heidelberg 69120, Germany.
Jochen HampeDepartment of Internal Medicine I, Hospital Schleswig-Holstein, Kiel 24105, Germany.
Kari HemminkiGerman Cancer Research Center, Heidelberg 69120, Germany.
Robert M W HofstraDepartment of Clinical Genetics, Erasmus Medical Center, Rotterdam 3000 CA, The Netherlands.
Emma NorthwoodSection of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK.
Claire PallesMolecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Manuela PinheiroDepartment of Genetics, Portugese Oncology Institute, Porto 4200-072, Portugal.
Clara Ruiz-PonteGalician Public Foundation of Genomic Medicine, Centro de Investigación Biomédica en Red de Enfermedades Rares, Genomics Medicine Group, Hospital Clínico, Santiago de Compostela, University of Santiago de Compostela, Galicia 15782, Spain.
Clemens SchafmayerDepartment of General and Thoracic Surgery, University Hospital Schleswig-Holstein, Kiel 24105, Germany.
Manuel R TeixeiraDepartment of Genetics, Portugese Oncology Institute, Porto 4200-072, Portugal.
Helga WestersUniversity of Gronigen, University Medical Centre Gronigen, Department of Genetics, Gronigen 9700 RB, The Netherlands.
Tom van WezelLeiden Department of Pathology, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
D Timothy BishopSection of Epidemiology and Biostatistics, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK.
Ian TomlinsonMolecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.
Malcolm G DunlopColon Cancer Genetics Group, Institute of Genetics and Molecular Medicine, University of Edinburgh and Medical Research Council (MRC) Human Genetics Unit, Edinburgh EH4 2XU, UK.
Richard S HoulstonDivision of Genetics and Epidemiology, The Institute of Cancer Research, Surrey, Sutton SM2 5NG, UK.

Funding

Cancer Research UK 10589Cancer Research UK 12076Cancer Research UK 15116Cancer Research UK 18927Cancer Research UK 19167Cancer Research UK C1298/A8362Cancer Research UK C348/A12076Cancer Research UK C588/A10589Medical Research Council G1001799Medical Research Council MC_PC_U127527198Medical Research Council MC_U127527198Medical Research Council MR/K018647/1Medical Research Council MR/N01104X/1Wellcome TrustWellcome Trust 090532/Z/09/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colorectal NeoplasmsSemaphorinsCase-Control StudiesHumansRiskRisk FactorsSemaphorins

Identifiers

PMID26961734
PMCPMC4792923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.